Efficacy and Safety of AFN-1252, the First Staphylococcus-Specific Antibacterial Agent, in the Treatment of Acute Bacterial Skin and Skin Structure Infections, Including Those in Patients with Significant Comorbidities
about
Development of ebsulfur analogues as potent antibacterials against methicillin-resistant Staphylococcus aureus.Environmental fatty acids enable emergence of infectious Staphylococcus aureus resistant to FASII-targeted antimicrobials.Studies of Staphylococcus aureus FabI inhibitors: fragment-based approach based on holographic structure-activity relationship analyses.Recent Advances in the Rational Design and Optimization of Antibacterial Agents.What we may expect from novel antibacterial agents in the pipeline with respect to resistance and pharmacodynamic principles.Exogenous fatty acid metabolism in bacteria.Therapeutic Targets in Chlamydial Fatty Acid and Phospholipid Synthesis
P2860
Q35987945-88705EA5-96A9-4351-8DC3-A6AF0D663D7AQ37329885-2D346384-8B50-4740-94DA-CA6EB8058246Q38765020-9578B983-B3D2-44B5-9853-3D69CBE13118Q38958278-00B992F1-DA45-4D4E-B811-1964A68660A7Q39120027-F2F650CE-ECD8-4AEB-B073-FDD5EA510ECAQ39408643-5C8D984D-E0B6-4EE8-8C0B-B67BE37DFDCDQ57492054-A320307B-160C-450F-A0BB-CB57F8CC7471
P2860
Efficacy and Safety of AFN-1252, the First Staphylococcus-Specific Antibacterial Agent, in the Treatment of Acute Bacterial Skin and Skin Structure Infections, Including Those in Patients with Significant Comorbidities
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Efficacy and Safety of AFN-125 ...... with Significant Comorbidities
@ast
Efficacy and Safety of AFN-125 ...... with Significant Comorbidities
@en
type
label
Efficacy and Safety of AFN-125 ...... with Significant Comorbidities
@ast
Efficacy and Safety of AFN-125 ...... with Significant Comorbidities
@en
prefLabel
Efficacy and Safety of AFN-125 ...... with Significant Comorbidities
@ast
Efficacy and Safety of AFN-125 ...... with Significant Comorbidities
@en
P2093
P2860
P356
P1476
Efficacy and Safety of AFN-125 ...... with Significant Comorbidities
@en
P2093
P2860
P304
P356
10.1128/AAC.01741-15
P407
P577
2015-12-28T00:00:00Z